Yuki Kageyama to Disease Progression
This is a "connection" page, showing publications Yuki Kageyama has written about Disease Progression.
Connection Strength
0.044
-
Intracavitary administration of OK-432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinoma. Int J Urol. 2002 Jan; 9(1):57-9.
Score: 0.031
-
Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999 Oct; 36(4):309-13.
Score: 0.007
-
Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998; 33(5):464-8.
Score: 0.006